Acadia Pharmaceuticals ACAD announced that it has signed an exclusive worldwide license agreement with Saniona, a Denmark-based clinical-stage biopharmaceutical company, to develop and commercialize ...
Zacks Investment Research on MSN
Why Acadia (ACAD) is poised to beat earnings estimates again
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Acadia Pharmaceuticals (ACAD), which ...
Stocktwits on MSN
Why did ACAD stock slump 8% after hours today?
CEO Catherine Owen Adams said that the negative trend vote is “disappointing” and “not what we hoped for.” ・The committee will formally adopt its opinion in February and the company will request a ...
Acadia Pharmaceuticals Inc. ACAD is a biopharmaceutical company focused on developing innovative medicines to address unmet medical needs in central nervous system (CNS) disorders. The company’s lead ...
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Fortrea Holdings Inc. (FTRE) and Acadia Pharmaceuticals (ACAD). But which of these two stocks is more ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of GSK (GSK) and Acadia Pharmaceuticals (ACAD). But which of these two stocks is more ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results